U.S. Online Retail and Ecommerce Stock News

Kimbell Royalty Partners (KRP) is back on investor radars after quarterly earnings topped analyst expectations, recent analyst upgrades, and a newly announced US$100 million unit buyback program that has focused attention on its cash return approach. See our latest analysis for Kimbell Royalty Partners. The recent 4.31% 1 day share price return, together with a 26.59% 90 day share price return and 37.43% 1 year total shareholder return, points to momentum building as investors react to...

Community Financial System (CBU) recently reported fourth quarter 2025 results, with operating EPS of US$1.12 coming in slightly below analyst expectations. Revenue of US$215.45 million came in ahead of forecasts. At the same time, the company extended its dividend track record, raising its payout for a 28th consecutive year. This combination of mixed earnings and ongoing shareholder returns is something many investors are weighing as they reassess the stock. See our latest analysis for...

Assessing recent moves in Farmers National Banc (FMNB) Farmers National Banc (FMNB) has drawn fresh attention after recent trading, with the share price at $13.41 and returns of 0.1% over the past day and about 2.4% over the past week. Over the past month the stock shows a return of about 7%, while the past 3 months reflect a slight 0.7% decline, prompting investors to reassess the regional bank's income profile and valuation. See our latest analysis for Farmers National Banc. Set against a...

Driven Brands Holdings has disclosed widespread accounting errors and material weaknesses in its internal controls, prompting plans to restate at least two years of financial statements and triggering multiple securities fraud class action lawsuits filed on behalf of shareholders. These revelations have not only raised serious questions about the reliability of past financial reporting, but also put corporate governance, capital allocation decisions, and management oversight under intense...

Oculis Holding (NasdaqGM:OCS) is back in focus after the European Medicines Agency granted PRIME designation to its neuroprotective candidate Privosegtor for optic neuritis, following earlier FDA Breakthrough Therapy and Orphan Drug recognitions. See our latest analysis for Oculis Holding. The EMA PRIME decision arrives after earlier FDA designations and comes at a time when Oculis Holding’s share price has a 90 day return of 27.42% and a 1 year total shareholder return of 85.32%. This...

The Morning Bull - US Market Morning Update Monday, Apr, 6 2026 US stock futures are pointing higher this morning, with E mini S&P 500 contracts up about 0.7% and Nasdaq 100 futures up just over 1%, as investors weigh a mix of strong jobs data and signs of cooling inflation. Nonfarm payrolls rose by 178,000 in March while unemployment sits at 4.3% and wage growth is 3.5% year on year, suggesting more people are working but pay pressures are easing. At the same time, the US Services PMI has...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

In March 2026, the FDA issued a warning letter finding ImmunityBio’s TV ad and podcast for its bladder cancer drug Anktiva false or misleading, and multiple law firms have since launched securities class actions alleging investors were misled about the drug’s capabilities and promotional practices. At the same time, interim data from the pivotal QUILT‑2.005 trial led an independent committee to confirm that the completed 366‑patient study is adequately powered for a planned supplemental FDA...

Reddit (NYSE:RDDT) has approved a $1b share repurchase program, aiming to buy back its own stock over time. The company has also been fined £14.47m by the UK's Information Commissioner's Office for child data privacy violations. These developments come as Reddit's share price stands at $136.0 after a 9.6% gain over the past week and a 43.8% decline year to date. Reddit's recent moves present a mixed picture to consider. On one side, the $1b buyback signals that management is prepared to...

VICI Properties Inc. recently expanded its role in the One Beverly Hills project by providing a US$1.50 billion mezzanine loan behind a US$2.80 billion senior facility and agreed to acquire casino and hotel real estate in Alberta that will be folded into its existing triple-net master lease with PURE. Together, these moves deepen VICI’s exposure to high-end experiential real estate while extending long-term, inflation-linked rental streams from both U.S. luxury mixed-use and Canadian gaming...

If you are wondering whether JD.com's current share price offers value or just extra risk, this breakdown will help you make sense of where the stock stands today. JD.com closed at US$28.46, with returns of a 1.7% decline over 7 days, 5.3% over 30 days, a 3.6% decline year to date, a 16.1% decline over 1 year, a 24.7% decline over 3 years, and a 60.2% decline over 5 years, which may change how you think about its potential and risk. Recent coverage of JD.com has focused on its position in...

Baxter International (BAX) has launched its IV Verify Line Labeling System at the 2026 American Organization for Nursing Leadership Conference, highlighting a new automation tool aimed at IV line identification, medication safety, and nurse workflow efficiency. See our latest analysis for Baxter International. Despite the IV Verify launch highlighting Baxter International's focus on bedside safety and workflow tools, the shares trade at US$16.68 after a 5.6% 7 day share price gain but a 41.0%...

Terreno Realty (TRNO) has been drawing fresh attention after recent share moves, with the stock up about 2.5% over the past week but slightly lower over the past month. See our latest analysis for Terreno Realty. The recent 2.5% 7 day share price return sits alongside a 5.3% year to date share price return and a 20.5% 1 year total shareholder return, which suggests momentum is building rather than fading. If this kind of steady trend interests you, it could be a good moment to broaden your...

In early April 2026, Baron Capital reiterated its positive stance on Host Hotels & Resorts in its Q4 2025 fund letter, while the company also received Nareit’s 2026 Leader in the Light Award for Operations for large-cap REITs, recognizing its sustainability and operational practices. Together, the institutional endorsement and sustainability recognition underscore how Host links environmental and social initiatives with financial discipline, strengthening its appeal to long-term, ESG-focused...

We can readily understand why investors are attracted to unprofitable companies. Indeed, vTv Therapeutics ( NASDAQ:VTVT...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Onto Innovation recently reported that strong demand for its metrology and inspection tools in AI and advanced semiconductor packaging, supported by a record backlog and a major volume agreement with a leading HBM maker, is driving expectations for more than 30% revenue growth in advanced packaging in 2026. This momentum not only reinforces Onto Innovation’s role in critical AI and high‑bandwidth memory production, but also highlights how higher-margin advanced packaging tools and improving...

Procore Technologies (PCOR) has reshuffled its top leadership, naming Rachel Pyles as Chief Financial Officer and Walt Hearn as Chief Revenue Officer, while reaffirming its 2026 guidance and continued focus on AI driven platform expansion. See our latest analysis for Procore Technologies. The leadership reshuffle comes as the share price trades at US$58.02, with a 7 day share price return of 4.05% and a 90 day share price return showing a 22.14% decline, while the 3 year total shareholder...

In early April 2026, Alkermes plc announced it had begun the Brilliance phase 3 program, a set of randomized, double-blind, placebo-controlled studies testing its oral orexin 2 receptor agonist alixorexton in adults with narcolepsy type 1 and type 2, following earlier phase 1 and phase 2 work and Breakthrough Therapy designation in narcolepsy type 1. The launch of these Brilliance Studies signals Alkermes’ intention to build a differentiated sleep-disorder franchise around orexin agonism,...

Recently, First Financial Bankshares’ board of directors promoted David Bailey to CEO and reported a record quarterly net income with strong deposit growth, while absorbing a US$21.55 million credit loss tied to fraudulent activity by a commercial borrower. This combination of leadership transition and resilient financial performance offers insight into how the bank is managing risk while pursuing its growth plans. We’ll explore how Bailey’s appointment and the record quarterly results shape...

Recent share performance and business mix Markel Group (MKL) has recently drawn attention after a one-month return of about a 4% decline and a past three-month return of roughly an 11% decline, contrasting with a positive one-year total return of 13.1%. The company operates across insurance and a range of industrial and consumer businesses. Markel Insurance generates about US$10.3b of revenue, alongside contributions from the Industrial, Consumer and Other, Financial, and Corporate...

Keybanc analyst Aleksey Yefremov recently shifted his rating on Avient (AVNT) from Overweight to Sector Weight, a change that puts fresh attention on how the stock compares with its peers. See our latest analysis for Avient. Avient shares recently pulled back, with a 1 day share price return of a 3.65% decline and a 30 day share price return of a 4.15% decline. However, the 1 year total shareholder return of 21.30% and the year to date share price return of 10.60% suggest momentum has...

Lindsay (LNN) is back in focus after reporting quarterly results that missed analyst expectations, with softer demand in both Irrigation and Infrastructure, weaker operating margins, and management flagging limited near term growth catalysts. See our latest analysis for Lindsay. The weak quarter has been followed by a sharp reset in expectations, with a 1 month share price return showing a decline of 20.51% and a 1 year total shareholder return showing a loss of 12.90%, pointing to fading...

EnerSys (ENS) has drawn attention after announcing the closure of its legacy lead-acid battery plant in Tijuana, with production shifting to its Thin Plate Pure Lead facility in Springfield, Missouri. See our latest analysis for EnerSys. The stock’s recent 14.32% 1 month share price return and 17.66% year to date share price return suggest momentum has been building, while the 120.67% 1 year total shareholder return points to stronger gains over a longer stretch. If you are looking beyond...